Ethics statements
This study was approved by our Clinical Trials and Biomedical Ethics Committee (number: 2021-1232) and registered with the Chinese Clinical Trials Registry (ChiCTR2200056549) on 7 February 2022. Written informed consent was obtained from all patients.